Adverum Biotechnologies to Host a Conference Call and Webcast to Report First Quarter 2020 Financial Results and Provide Corp...
May 21 2020 - 4:05PM
Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene
therapy company targeting unmet medical needs in ocular and rare
diseases, today announced that it will host a conference call and
audio webcast on Thursday, May 28, 2020 at 1:30 pm PT / 4:30 pm ET
to report its first quarter 2020 financial results and provide an
update on recent business progress.
The live audio webcast will be accessible under
Events and Presentations in the Investors section of the company's
website. To participate in the conference call, dial 1-866-420-8347
(domestic) or 1-409-217-8241 (international) and refer to the
“Adverum Biotechnologies’ First Quarter 2020 Earnings Call.” It is
recommended call participants dial in 15 minutes in advance. The
archived audio webcast will be available on the Adverum website
following the call and will be available for 30 days.
About Adverum BiotechnologiesAdverum
Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy
company targeting unmet medical needs in serious ocular and rare
diseases. Adverum is evaluating its novel gene therapy candidate,
ADVM-022, as a one-time, intravitreal injection for the treatment
of its lead indication, wet age-related macular degeneration. For
more information, please visit www.adverum.com.
Investor and Media Inquiries:
Investors:
Myesha Lacy
Adverum Biotechnologies, Inc.
mlacy@adverum.com
1-650-649-1257
Media:
Cherilyn Cecchini, M.D.
LifeSci Communications
ccecchini@lifescicomms.com
1-646-876-5196
Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From Apr 2023 to Apr 2024